Respiratory Care Devices Global Market - Forecast to 2029
Respiratory Care Devices Global Market - Forecast to 2029
Abstract
Respiratory disease is the diseases and disorders of the airways and the lungs that affect human respiration. Respiratory diseases such as asthma, chronic obstructive pulmonary diseases (COPD), sleep apnea and others may be caused by infection, by smoking tobacco, or by breathing in second hand tobacco smoke, radon, asbestos, or other forms of air pollution. Respiratory care device are used for the diagnosis, treatment and monitoring of Respiratory diseases. These devices help patients in need of support for breathing, removal of carbon dioxide, and therapy to reduce disuse atrophy of abdominal wall muscles. Technological advancements in respiratory care devices and funding for the development of innovative respiratory technologies further boost the growth of market.
According to IQ4I analysis, the respiratory care devices global market is estimated is expected to grow at a mid single digit CAGR from 2022 to 2029 to reach $24,866.6 million by 2029. The market is being propelled by several factors, including the rising incidence and prevalence of respiratory diseases like Asthma, COPD, and others. The growing elderly population and the subsequent rise in the occurrence of respiratory disorders also contribute to the market's growth. Whereas rising use of non – invasive respiratory care devices, advancements in respiratory care devices, funding for the development of innovative respiratory care technologies and favorable reimbursement are providing immense opportunities to the market. However, product recalls, adverse effects associated with some of the respiratory care devices, availability of alternative respiratory care devices and stringent regulations are hampering the growth of the market.
The respiratory care devices market is segmented based on the product, application, end – user and geography. Based on the product, the respiratory care devices market is segmented as diagnostic, therapeutic, monitoring devices, and consumables. Among these, therapeutic devices market commanded the largest revenue in 2022 and is expected to grow at a mid single digit CAGR from 2022 to 2029. The therapeutic devices market is sub – segmented into Humidifier, Nebulizers, Oxygen concentrators, PAP devices, Resuscitators, Ventilators, Inhalers, Neuromodulation devices and Airway Clarence devices & others. Among these, PAP devices global market accounted for the largest revenue in 2022 and is expected to grow at a high single digit CAGR from 2022 to 2029. Neuromodulation devices market is expected to grow at a high double digit CAGR from 2022 to 2029.
Humidifier global market is further classified into Active Humidifiers and Passive Humidifiers. Among these, Active Humidifiers accounted for the largest revenue in 2022 and is expected to grow at a low single digit CAGR from 2022 to 2029. Nebulizer’s global market is segmented into Jet Nebulizer, Ultrasonic Nebulizer, Mesh Nebulizer and Smart Nebulizers. Among these, Jet Nebulizer is accounted for the largest revenue in 2022 and is expected to grow at a mid single digit CAGR from 2022 to 2029. Smart Nebulizers is expected to grow at a mid single digit CAGR from 2022 to 2029. Oxygen Concentrators global market is segmented into Stationary Oxygen Concentrators and Portable Oxygen Concentrators. Among these, Portable Oxygen Concentrators is accounted for the largest revenue in 2022 and is expected to grow at a high single digit CAGR from 2022 to 2029.
Positive Airway Pressure Devices (PAP) Global Market is segmented into Continuous PAP Devices (CPAP), Automatic PAP (APAP) Devices and Bi-Level PAP (BPAP) Devices. Among these, Automatic PAP (APAP) Devices market accounted for the largest revenue in 2022 and is expected to grow at a double digit CAGR from 2022 to 2029. Resuscitators global market is segmented into Manual Resuscitator and Gas Powdered Resuscitator. Among these, Manual Resuscitator accounted for the largest revenue in 2022 and is expected to grow at a low single digit CAGR from 2022 to 2029. Ventilators global market is segmented into ICU Ventilator, Emergency and Transport Ventilator and Others. Among these, Emergency and Transport Ventilator global market is accounted for the largest revenue of in 2022 and is expected to grow at a mid single digit CAGR from 2022 to 2029. Inhalers global market is segmented into Dry Powder Inhalers, Metered Dose Inhalers and Soft Mist Inhalers. Among these, Metered Dose Inhalers accounted for the largest revenue in 2022 and is expected to grow at a high single digit CAGR from 2022 to 2029. Soft Mist Inhaler is expected to grow at a mid teen CAGR from 2022 to 2029.
Monitoring devices global market is segmented Pulse Oximeters, Capnographs and Gas analyzers and others. Among these, Pulse Oximeters accounted for the largest revenue in 2022 and is expected to grow at a low single digit CAGR from 2022 to 2029. Capnographs is expected to grow at a low single digit CAGR from 2022 to 2029. Pulse Oximeters global market is segmented into Finger Pulse Oximeters, Handheld Pulse Oximeters, Tabletop Pulse Oximeters and Others. Among these, Handheld Pulse Oximeters accounted for the largest revenue in 2022 and is expected to grow at a low single digit CAGR from 2022 to 2029. Finger Pulse Oximeters is expected to grow at a low single digit CAGR from 2022 to 2029. Diagnostic device segment is further classified into Spirometers, Peak flow meter, Polysomnograph devices, Respiratory polygraph and others.
Among these, Spirometers accounted for the largest revenue in 2022 and is expected to grow at a low single digit CAGR from 2022 to 2029. Polysomnograph devices are expected to grow at a mid single digit CAGR from 2022 to 2029. Spirometers segment is further classified into Volumetric Spirometers and Flow Measuring Spirometers. Among these, Flow Measuring Spirometers is accounted for the largest revenue of in 2022 and is expected to grow at a mid single digit CAGR from 2022 to 2029. Polysomnograph devices segmented into Clinical Polysomnograph Devices and Ambulatory Polysomnographs Devices. Among these, Clinical Polysomnograph Devices accounted for the largest revenue in 2022 and is expected to grow at a mid single digit CAGR from 2022 to 2029. Consumables global market is classified into Masks, Air Management appliances, Nasal cannula, Filters and Others Consumables. Among these, Masks accounted for the largest revenue in 2022 and is expected to grow at a mid single digit CAGR from 2022 to 2029.
The respiratory care devices market based on application is segmented into obstructive, restrictive, vascular, infectious and other respiratory conditions. Among applications, obstructive respiratory conditions commanded the largest revenue in 2022. The market is expected to grow at a mid single digit CAGR from 2022 to 2029. The obstructive respiratory conditions are further segmented into COPD (chronic bronchitis and emphysema), asthma, cystic fibrosis, and obstructive sleep apnea, among these; Obstructive Sleep Apnea commanded the largest share in 2022 and is expected to grow at a high single digit CAGR from 2022 to 2029. COPD market is further segmented into Chronic Bronchitis and Emphysema. Among these, Chronic Bronchitis global market is accounted for the highest revenue in 2022 and is expected to grow at high single digit CAGR from 2022 to 2029.
Restrictive respiratory condition is further segmented into ARDS and Restrictive Lung Diseases and others. Among these, ARDS segment accounted for the highest revenue in 2022 and is expected to grow at a mid single digit CAGR from 2022 to 2029. Vascular Diseases is further classified into Pulmonary Fibrosis, Pulmonary Edema and Pulmonary Hypertension. Among these, Pulmonary Edema accounted for the highest revenue in 2022 and is expected to grow at a mid single digit CAGR from 2022 to 2029. Pulmonary Fibrosis is expected to grow at a mid single digit CAGR from 2022 to 2029. Infectious respiratory condition is further segmented into Pneumonia, Tuberculosis and COVID-19. Among these, Pneumonia sub – segment is accounted for the largest revenue in 2022 and is expected to grow at a mid single digit CAGR from 2022 to 2029. Tuberculosis is expected to grow at a high single digit CAGR from 2022 to 2029.
The end-users market is segmented into hospitals, home care and ambulatory surgical centers, among them, hospital care settings commanded the largest revenue in 2022. The market is expected to grow at a mid single digit CAGR from 2022 to 2029. The Homecare setting is expected to grow at a high single digit CAGR from 2022 to 2029. Respiratory home healthcare has opened new opportunities for the respiratory care devices market. The hospital end-user segment is further sub-segmented based on care settings into emergency care, critical care/ICU, acute care, sleep center and others. The critical care segment commanded the largest revenue in 2022 and is expected to grow at a mid single digit CAGR from 2022 to 2029. The sleep centers are expected to grow at mid single digit CAGR from 2022 to 2029.
The geographic market is segmented into North America, Europe, Asia-Pacific and Rest of the World. Among these, North-America commanded the largest revenue in 2022. The market is expected to grow at a mid single digit CAGR from 2022 to 2029. The factors such as increasing healthcare expenditure, rising prevalence of respiratory disorders, increasing aging population, favorable reimbursement policies, government initiatives focus on promoting research, development, and access to innovative respiratory care technologies (For instance, Asthma and Allergy Foundation of America (AAFA) dedicated to saving lives and reducing the burden of disease for people with asthma and allergies through support, advocacy, education, and research), launch of advanced respiratory care devices by the companies, acquisition of respiratory care based companies to expand their market reach and receiving funding to develop advanced respiratory care products are driving the North America respiratory care devices market.
Asia-Pacific is expected to grow at a high single digit CAGR from 2022 to 2029. Asia-Pacific tends to be fastest-growing segment due to increasing healthcare expenditure, increasing incidence and prevalence of respiratory disease, increasing in aging population, high acceptance of technological advancements, government initiatives to increase awareness by education campaigns and development of advanced affordable and low cost respiratory products.
The major companies in Respiratory care devices are Medtronic (Ireland), Getinge Groups (Maquet GmbH) (Sweden), Vyaire Medical, Inc (U.S.), Resmed Inc (U.S.), Philips N.V. (TheNetherlands), Fisher and Paykel healthcare (New Zealand), Dragerwerk AG & Co. KGaA (Germany), Air Liquide S.A (France), Masimo (U.S.) and Inspire Medical (U.S.)
Content
Table of Contents
1 EXECUTIVE SUMMARY 35
2 INTRODUCTION 42
2.1 KEY TAKEAWAYS 42
2.2 REPORT SCOPE 43
2.3 REPORT DESCRIPTION 43
2.4 MARKETS COVERED 47
2.5 STAKEHOLDERS 51
2.6 RESEARCH METHODOLOGY 51
2.6.1 MARKET SIZE ESTIMATION 54
2.6.2 MARKET CRACKDOWN AND DATATRIANGULATION 56
2.6.3 SECONDARY SOURCES 57
2.6.4 PRIMARY SOURCES 57
2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES 58
2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES 58
2.6.7 ASSUMPTIONS 59
3 MARKET OVERVIEW 60
3.1 INTRODUCTION 60
3.2 MARKET SEGMENTATION 61
3.3 FACTORS INFLUENCING MARKET 64
3.4 MARKET DYNAMICS 65
3.4.1 DRIVERS AND OPPORTUNITIES 65
3.4.1.1 Rising incidences of respiratory diseases such as copd, asthma, and sleep apnea, which has resulted in a higher demand for respiratory care devices 65
3.4.1.2 Growing geriatric population and the consequent increase in the incidence of respiratory disorders among them, creating a substantial demand for respiratory care devices 66
3.4.1.3 Rising use of non-invasive respiratory care devices 67
3.4.1.4 Advancements in respiratory care devices and funding for the development of innovative respiratory care technologies 68
3.4.1.5 Favorable reimbursement scenario 70
3.4.2 RESTRAINTS AND THREATS 72
3.4.2.1 Product recalls 72
3.4.2.2 Harmful side effects associated with the use of certain respiratory care devices 73
3.4.2.3 Availability of low-cost products from local manufacturers 74
3.4.2.4 Availability of alternatives treatments such as medication and surgery 74
3.4.2.5 Stringent regulatory policies 75
3.5 REGULATORY AFFAIRS 76
3.5.1 U.S. 76
3.5.2 EUROPE 78
3.5.3 INDIA 79
3.5.4 CHINA 80
3.5.5 JAPAN 81
3.5.6 ISO STANDARDS 82
3.6 PORTER’S FIVE FORCE ANALYSIS 88
3.6.1 THREAT OF NEW ENTRANTS 89
3.6.2 THREAT OF SUBSTITUTES 90
3.6.3 COMPETITIVE RIVALRY 90
3.6.4 BARGAINING POWER OF SUPPLIERS 91
3.6.5 BARGAINING POWER OF BUYERS 92
3.7 SUPPLY CHAIN ANALYSIS 93
3.8 MARKET SHARE ANALYSIS 96
3.8.1 RESPIRATORY CARE DEVICES GLOBAL MARKET SHARE 96
3.8.2 VENTILATOR GLOBAL MARKET SHARE ANALYSIS 100
3.8.3 PAP GLOBAL MARKET SHARE ANALYSIS 103
3.8.4 CPAP GLOBAL MARKET SHARE ANALYSIS 105
3.8.5 APAP GLOBAL MARKET SHARE ANALYSIS 106
3.8.6 BPAP GLOBAL MARKET SHARE ANALYSIS 108
3.9 REIMBURSEMENT SCENARIO 109
3.10 TECHNOLOGICAL ADVANCEMENTS 112
3.10.1 INTEGRATED DEVICES 113
3.10.2 NON – INVASIVE NANOSENSOR BASED WEARBLE RESPIRATORY MONITORING 113
3.10.3 AI BASED RESPIRATORY MONITORING 114
3.10.4 HIGH VELOCITY THERAPY 115
3.10.5 DIGITAL TECHNOLOGIES IN RESPIRATORY DEVICES 115
3.10.6 ADVANCED NEONATAL RESPIRATORY SOLUTIONS 116
3.10.6.1 Neonatal lung monitoring 116
3.10.6.2 Neovent 117
3.10.7 SELF - CARE RESPIRATORY MONITOR 117
3.11 FUNDING SCENARIO 117
3.12 CLINICAL TRIALS 124
4 RESPIRATORY CARE DEVICES GLOBAL MARKET, BASED ON PRODUCTS 127
4.1 INTRODUCTION 127
4.2 THERAPEUTIC RESPIRATORY CARE DEVICES 131
4.2.1 HUMIDIFIERS 134
4.2.1.1 Active humidifiers 138
4.2.1.2 Passive humidifiers 141
4.2.2 NEBULIZERS 143
4.2.2.1 Jet nebulizers 148
4.2.2.2 Ultrasonic nebulizers 150
4.2.2.3 Mesh nebulizers 153
4.2.2.4 Smart nebulizers 156
4.2.3 OXYGEN CONCENTRATORS 157
4.2.3.1 Stationary oxygen concentrators 162
4.2.3.2 Portable oxygen concentrators 164
4.2.4 POSITIVE AIRWAY PRESSURE DEVICES (PAP) 166
4.2.4.1 Continuous pap devices (CPAP) 171
4.2.4.2 Automatic pap (APAP) devices 173
4.2.4.3 Bbi-level pap (BPAP) devices 175
4.2.5 RESUSCITATORS 177
4.2.5.1 Manual resuscitators 181
4.2.5.2 Gas powered resuscitators 183
4.2.6 VENTILATORS 185
4.2.7 VENTILATORs MARKET BASED ON TYPE 190
4.2.7.1 ICU ventilators 192
4.2.7.2 Emergency and transport ventilators 195
4.2.7.3 Others 197
4.2.8 VENTILATORs MARKET BASED ON END-USERS 199
4.2.9 INHALERS 208
4.2.9.1 Dry powder inhalers 212
4.2.9.2 Metered dose inhalers 215
4.2.9.3 Soft mist inhalers 218
4.2.10 NEUROMODULATION DEVICES 221
4.2.11 AIRWAY CLEARANCE DEVICES AND OTHERS 224
4.3 MONITORING RESPIRATORY CARE DEVICES 235
4.3.1 PULSE OXIMETERS 239
4.3.1.1 Finger pulse oximeters 243
4.3.1.2 Handheld pulse oximeters 244
4.3.1.3 Tabletop pulse oximeters 246
4.3.1.4 Others 247
4.3.2 CAPNOGRAPHS 249
4.3.3 GAS ANALYZERS AND OTHERS 251
4.4 DIAGNOSTIC RESPIRATORY CARE DEVICES 253
4.4.1 SPIROMETERS 257
4.4.1.1 Volumetric spirometers 261
4.4.1.2 Flow measuring spirometers 263
4.4.2 PEAK FLOW METERS 265
4.4.3 POLYSOMNOGRAPH DEVICES (PSG) 267
4.4.3.1 Clinical polysomnography devices 270
4.4.3.2 Ambulatory polysomnography devices 271
4.4.4 RESPIRATORY POLYGRAPH 273
4.4.5 OTHER DIAGNOSTIC DEVICES 274
4.5 CONSUMABLES 276
4.5.1 MASKS 280
4.5.1.1 Full face masks 283
4.5.1.2 Nasal masks 284
4.5.1.3 Nasal pillow masks 286
4.5.1.4 Other masks 287
4.5.2 AIRWAY MANAGNEMNT APPLIENCES 289
4.5.3 NASAL CANNULAS 293
4.5.4 FILTERS 295
4.5.5 OTHER CONSUMABLES 296
5 RESPIRATORY CARE DEVICES GLOBAL MARKET, BASED ON
APPLICATION 299
5.1 INTRODUCTION 299
5.2 OBSTRUCTIVE RESPIRATORY CONDITION 301
5.2.1 CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) 306
5.2.1.1 Chronic bronchitis 311
5.2.1.2 Emphysema 313
5.2.2 ASTHMA 314
5.2.3 CYSTIC FIBROSIS 316
5.2.4 OBSTRUCTIVE SLEEP APNEA (OSA) 318
5.3 RESTRICTIVE RESPIRATORY CONDITION 321
5.3.1 ARDS 325
5.3.2 RESTRECTIVE LUNG DISEASES AND OTHERS 326
5.4 VASCULAR DISEASES 328
5.4.1 PULMONARY FIBROSIS 332
5.4.2 PULMONARY EDEMA 334
5.4.3 PULMONARY HYPERTENSION (PH) 335
5.5 INFECTIOUS RESPIRATORY CONDITION 337
5.5.1 PNEUMONIA 341
5.5.2 TUBERCULOSIS 342
5.5.3 COVID - 19 344
5.6 OTHERS 346
6 RESPIRATORY CARE DEVICES GLOBAL MARKETY, BASED ON END-USERS 348
6.1 INTRODUCTION 348
6.2 HOSPITALS 351
6.2.1 EMERGENCY CARE 355
6.2.2 CRITICAL CARE/INTENSIVE CARE UNIT (ICU) 357
6.2.3 ACUTE CARE 358
6.2.4 SLEEP CENTER UNIT 359
6.2.5 OTHER HOSPITAL CARE SETTINGS (OPD) 360
6.3 HOME HEALTH CARE 361
6.4 AMBULATORY SURGICAL CENTERS 363
7 REGIONAL MARKET ANALYSIS 365
7.1 INTRODUCTION 365
7.2 NORTH AMERICA 370
7.2.1 UNITED STATES (U.S.) 418
7.2.2 REST OF NORTH AMERICA 422
7.3 EUROPE 425
7.3.1 GERMANY 474
7.3.2 ITALY 477
7.3.3 FRANCE 479
7.3.4 REST OF EUROPE 482
7.4 ASIA-PACIFIC 485
7.4.1 JAPAN 534
7.4.2 CHINA 536
7.4.3 INDIA 538
7.4.4 REST OF APAC 541
7.5 REST OF THE WORLD 544
7.5.1 BRAZIL 593
7.5.2 REST OF LATIN AMERICA 595
7.5.3 MIDDLE EAST AND OTHER COUNTRIES 597
8 COMPANY DEVELOPMENTS 600
8.1 INTRODUCTION 600
8.2 NEW PRODUCT LAUNCHES 601
8.3 APPROVALS 604
8.4 AGREEMENT 605
8.5 EXPANSION 605
9 MAJOR COMPANIES 607
9.1 AIR LIQUIDE S.A 607
9.1.1 OVERVIEW 607
9.1.2 FINANCIALS 608
9.1.3 PRODUCT PORTFOLIO 609
9.1.4 KEY DEVELOPMENTS 610
9.1.5 BUSINESS STRATEGY 610
9.1.6 SWOT ANALYSIS 611
9.2 DRAGERWERK AG & CO. KGAA 612
9.2.1 OVERVIEW 612
9.2.2 FINANCIALS 613
9.2.3 PRODUCT PORTFOLIO 614
9.2.4 KEY DEVELOPMENTS 615
9.2.5 BUSINESS STRATEGY 616
9.2.6 SWOT ANALYSIS 616
9.3 FISHER AND PAYKEL HEALTHCARE CORPORATION LIMITED 617
9.3.1 OVERVIEW 617
9.3.2 FINANCIALS 618
9.3.3 PRODUCT PORTFOLIO 621
9.3.4 KEY DEVELOPMENTS 623
9.3.5 BUSINESS STRATEGY 624
9.3.6 SWOT ANALYSIS 625
9.4 INSPIRE MEDICAL SYSTEM, INC. 626
9.4.1 OVERVIEW 626
9.4.2 FINANCIALS 627
9.4.3 PRODUCT PORTFOLIO 628
9.4.4 KEY DEVELOPMENTS 628
9.4.5 BUSINESS STRATEGY 629
9.4.6 SWOT ANALYSIS 630
9.5 GETINGE GROUPS 631
9.5.1 OVERVIEW 631
9.5.2 FINANCIALS 632
9.5.3 PRODUCT PORTFOLIO 634
9.5.4 KEY DEVELOPMENTS 634
9.5.5 BUSINESS STRATEGY 634
9.5.6 SWOT ANALYSIS 635
9.6 MASIMO CORPORATION 636
9.6.1 OVERVIEW 636
9.6.2 FINANCIALS 637
9.6.3 PRODUCT PORTFOLIO 638
9.6.4 KEY DEVELOPMENTS 639
9.6.5 BUSINESS STRATEGY 639
9.6.6 SWOT ANALYSIS 640
9.7 MEDTRONIC, PLC 641
9.7.1 OVERVIEW 641
9.7.2 FINANCIALS 642
9.7.3 PRODUCT PORTFOLIO 645
9.7.4 KEY DEVELOPMENTS 648
9.7.5 BUSINESS STRATEGY 649
9.7.6 SWOT ANALYSIS 650
9.8 PHILIPS N.V. 651
9.8.1 OVERVIEW 651
9.8.2 FINANCIALS 652
9.8.3 PRODUCT PORTFOLIO 653
9.8.4 KEY DEVELOPMENTS 658
9.8.5 BUSINESS STRATEGY 658
9.8.6 SWOT ANALYSIS 659
9.9 RESMED INC. 660
9.9.1 OVERVIEW 660
9.9.2 FINANCIALS 661
9.9.3 PRODUCT PORTFOLIO 662
9.9.4 KEY DEVELOPMENTS 664
9.9.5 BUSINESS STRATEGY 664
9.9.6 SWOT ANALYSIS 666
9.10 VYAIRE MEDICAL, INC. 667
9.10.1 OVERVIEW 667
9.10.2 FINANCIALS 667
9.10.3 PRODUCT PORTFOLIO 667
9.10.4 KEY DEVELOPMENTS 669
9.10.5 BUSINESS STRATEGY 670
9.10.6 SWOT ANALYSIS 671
According to IQ4I analysis, the respiratory care devices global market is estimated is expected to grow at a mid single digit CAGR from 2022 to 2029 to reach $24,866.6 million by 2029. The market is being propelled by several factors, including the rising incidence and prevalence of respiratory diseases like Asthma, COPD, and others. The growing elderly population and the subsequent rise in the occurrence of respiratory disorders also contribute to the market's growth. Whereas rising use of non – invasive respiratory care devices, advancements in respiratory care devices, funding for the development of innovative respiratory care technologies and favorable reimbursement are providing immense opportunities to the market. However, product recalls, adverse effects associated with some of the respiratory care devices, availability of alternative respiratory care devices and stringent regulations are hampering the growth of the market.
The respiratory care devices market is segmented based on the product, application, end – user and geography. Based on the product, the respiratory care devices market is segmented as diagnostic, therapeutic, monitoring devices, and consumables. Among these, therapeutic devices market commanded the largest revenue in 2022 and is expected to grow at a mid single digit CAGR from 2022 to 2029. The therapeutic devices market is sub – segmented into Humidifier, Nebulizers, Oxygen concentrators, PAP devices, Resuscitators, Ventilators, Inhalers, Neuromodulation devices and Airway Clarence devices & others. Among these, PAP devices global market accounted for the largest revenue in 2022 and is expected to grow at a high single digit CAGR from 2022 to 2029. Neuromodulation devices market is expected to grow at a high double digit CAGR from 2022 to 2029.
Humidifier global market is further classified into Active Humidifiers and Passive Humidifiers. Among these, Active Humidifiers accounted for the largest revenue in 2022 and is expected to grow at a low single digit CAGR from 2022 to 2029. Nebulizer’s global market is segmented into Jet Nebulizer, Ultrasonic Nebulizer, Mesh Nebulizer and Smart Nebulizers. Among these, Jet Nebulizer is accounted for the largest revenue in 2022 and is expected to grow at a mid single digit CAGR from 2022 to 2029. Smart Nebulizers is expected to grow at a mid single digit CAGR from 2022 to 2029. Oxygen Concentrators global market is segmented into Stationary Oxygen Concentrators and Portable Oxygen Concentrators. Among these, Portable Oxygen Concentrators is accounted for the largest revenue in 2022 and is expected to grow at a high single digit CAGR from 2022 to 2029.
Positive Airway Pressure Devices (PAP) Global Market is segmented into Continuous PAP Devices (CPAP), Automatic PAP (APAP) Devices and Bi-Level PAP (BPAP) Devices. Among these, Automatic PAP (APAP) Devices market accounted for the largest revenue in 2022 and is expected to grow at a double digit CAGR from 2022 to 2029. Resuscitators global market is segmented into Manual Resuscitator and Gas Powdered Resuscitator. Among these, Manual Resuscitator accounted for the largest revenue in 2022 and is expected to grow at a low single digit CAGR from 2022 to 2029. Ventilators global market is segmented into ICU Ventilator, Emergency and Transport Ventilator and Others. Among these, Emergency and Transport Ventilator global market is accounted for the largest revenue of in 2022 and is expected to grow at a mid single digit CAGR from 2022 to 2029. Inhalers global market is segmented into Dry Powder Inhalers, Metered Dose Inhalers and Soft Mist Inhalers. Among these, Metered Dose Inhalers accounted for the largest revenue in 2022 and is expected to grow at a high single digit CAGR from 2022 to 2029. Soft Mist Inhaler is expected to grow at a mid teen CAGR from 2022 to 2029.
Monitoring devices global market is segmented Pulse Oximeters, Capnographs and Gas analyzers and others. Among these, Pulse Oximeters accounted for the largest revenue in 2022 and is expected to grow at a low single digit CAGR from 2022 to 2029. Capnographs is expected to grow at a low single digit CAGR from 2022 to 2029. Pulse Oximeters global market is segmented into Finger Pulse Oximeters, Handheld Pulse Oximeters, Tabletop Pulse Oximeters and Others. Among these, Handheld Pulse Oximeters accounted for the largest revenue in 2022 and is expected to grow at a low single digit CAGR from 2022 to 2029. Finger Pulse Oximeters is expected to grow at a low single digit CAGR from 2022 to 2029. Diagnostic device segment is further classified into Spirometers, Peak flow meter, Polysomnograph devices, Respiratory polygraph and others.
Among these, Spirometers accounted for the largest revenue in 2022 and is expected to grow at a low single digit CAGR from 2022 to 2029. Polysomnograph devices are expected to grow at a mid single digit CAGR from 2022 to 2029. Spirometers segment is further classified into Volumetric Spirometers and Flow Measuring Spirometers. Among these, Flow Measuring Spirometers is accounted for the largest revenue of in 2022 and is expected to grow at a mid single digit CAGR from 2022 to 2029. Polysomnograph devices segmented into Clinical Polysomnograph Devices and Ambulatory Polysomnographs Devices. Among these, Clinical Polysomnograph Devices accounted for the largest revenue in 2022 and is expected to grow at a mid single digit CAGR from 2022 to 2029. Consumables global market is classified into Masks, Air Management appliances, Nasal cannula, Filters and Others Consumables. Among these, Masks accounted for the largest revenue in 2022 and is expected to grow at a mid single digit CAGR from 2022 to 2029.
The respiratory care devices market based on application is segmented into obstructive, restrictive, vascular, infectious and other respiratory conditions. Among applications, obstructive respiratory conditions commanded the largest revenue in 2022. The market is expected to grow at a mid single digit CAGR from 2022 to 2029. The obstructive respiratory conditions are further segmented into COPD (chronic bronchitis and emphysema), asthma, cystic fibrosis, and obstructive sleep apnea, among these; Obstructive Sleep Apnea commanded the largest share in 2022 and is expected to grow at a high single digit CAGR from 2022 to 2029. COPD market is further segmented into Chronic Bronchitis and Emphysema. Among these, Chronic Bronchitis global market is accounted for the highest revenue in 2022 and is expected to grow at high single digit CAGR from 2022 to 2029.
Restrictive respiratory condition is further segmented into ARDS and Restrictive Lung Diseases and others. Among these, ARDS segment accounted for the highest revenue in 2022 and is expected to grow at a mid single digit CAGR from 2022 to 2029. Vascular Diseases is further classified into Pulmonary Fibrosis, Pulmonary Edema and Pulmonary Hypertension. Among these, Pulmonary Edema accounted for the highest revenue in 2022 and is expected to grow at a mid single digit CAGR from 2022 to 2029. Pulmonary Fibrosis is expected to grow at a mid single digit CAGR from 2022 to 2029. Infectious respiratory condition is further segmented into Pneumonia, Tuberculosis and COVID-19. Among these, Pneumonia sub – segment is accounted for the largest revenue in 2022 and is expected to grow at a mid single digit CAGR from 2022 to 2029. Tuberculosis is expected to grow at a high single digit CAGR from 2022 to 2029.
The end-users market is segmented into hospitals, home care and ambulatory surgical centers, among them, hospital care settings commanded the largest revenue in 2022. The market is expected to grow at a mid single digit CAGR from 2022 to 2029. The Homecare setting is expected to grow at a high single digit CAGR from 2022 to 2029. Respiratory home healthcare has opened new opportunities for the respiratory care devices market. The hospital end-user segment is further sub-segmented based on care settings into emergency care, critical care/ICU, acute care, sleep center and others. The critical care segment commanded the largest revenue in 2022 and is expected to grow at a mid single digit CAGR from 2022 to 2029. The sleep centers are expected to grow at mid single digit CAGR from 2022 to 2029.
The geographic market is segmented into North America, Europe, Asia-Pacific and Rest of the World. Among these, North-America commanded the largest revenue in 2022. The market is expected to grow at a mid single digit CAGR from 2022 to 2029. The factors such as increasing healthcare expenditure, rising prevalence of respiratory disorders, increasing aging population, favorable reimbursement policies, government initiatives focus on promoting research, development, and access to innovative respiratory care technologies (For instance, Asthma and Allergy Foundation of America (AAFA) dedicated to saving lives and reducing the burden of disease for people with asthma and allergies through support, advocacy, education, and research), launch of advanced respiratory care devices by the companies, acquisition of respiratory care based companies to expand their market reach and receiving funding to develop advanced respiratory care products are driving the North America respiratory care devices market.
Asia-Pacific is expected to grow at a high single digit CAGR from 2022 to 2029. Asia-Pacific tends to be fastest-growing segment due to increasing healthcare expenditure, increasing incidence and prevalence of respiratory disease, increasing in aging population, high acceptance of technological advancements, government initiatives to increase awareness by education campaigns and development of advanced affordable and low cost respiratory products.
The major companies in Respiratory care devices are Medtronic (Ireland), Getinge Groups (Maquet GmbH) (Sweden), Vyaire Medical, Inc (U.S.), Resmed Inc (U.S.), Philips N.V. (TheNetherlands), Fisher and Paykel healthcare (New Zealand), Dragerwerk AG & Co. KGaA (Germany), Air Liquide S.A (France), Masimo (U.S.) and Inspire Medical (U.S.)
1 EXECUTIVE SUMMARY 35
2 INTRODUCTION 42
2.1 KEY TAKEAWAYS 42
2.2 REPORT SCOPE 43
2.3 REPORT DESCRIPTION 43
2.4 MARKETS COVERED 47
2.5 STAKEHOLDERS 51
2.6 RESEARCH METHODOLOGY 51
2.6.1 MARKET SIZE ESTIMATION 54
2.6.2 MARKET CRACKDOWN AND DATATRIANGULATION 56
2.6.3 SECONDARY SOURCES 57
2.6.4 PRIMARY SOURCES 57
2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES 58
2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES 58
2.6.7 ASSUMPTIONS 59
3 MARKET OVERVIEW 60
3.1 INTRODUCTION 60
3.2 MARKET SEGMENTATION 61
3.3 FACTORS INFLUENCING MARKET 64
3.4 MARKET DYNAMICS 65
3.4.1 DRIVERS AND OPPORTUNITIES 65
3.4.1.1 Rising incidences of respiratory diseases such as copd, asthma, and sleep apnea, which has resulted in a higher demand for respiratory care devices 65
3.4.1.2 Growing geriatric population and the consequent increase in the incidence of respiratory disorders among them, creating a substantial demand for respiratory care devices 66
3.4.1.3 Rising use of non-invasive respiratory care devices 67
3.4.1.4 Advancements in respiratory care devices and funding for the development of innovative respiratory care technologies 68
3.4.1.5 Favorable reimbursement scenario 70
3.4.2 RESTRAINTS AND THREATS 72
3.4.2.1 Product recalls 72
3.4.2.2 Harmful side effects associated with the use of certain respiratory care devices 73
3.4.2.3 Availability of low-cost products from local manufacturers 74
3.4.2.4 Availability of alternatives treatments such as medication and surgery 74
3.4.2.5 Stringent regulatory policies 75
3.5 REGULATORY AFFAIRS 76
3.5.1 U.S. 76
3.5.2 EUROPE 78
3.5.3 INDIA 79
3.5.4 CHINA 80
3.5.5 JAPAN 81
3.5.6 ISO STANDARDS 82
3.6 PORTER’S FIVE FORCE ANALYSIS 88
3.6.1 THREAT OF NEW ENTRANTS 89
3.6.2 THREAT OF SUBSTITUTES 90
3.6.3 COMPETITIVE RIVALRY 90
3.6.4 BARGAINING POWER OF SUPPLIERS 91
3.6.5 BARGAINING POWER OF BUYERS 92
3.7 SUPPLY CHAIN ANALYSIS 93
3.8 MARKET SHARE ANALYSIS 96
3.8.1 RESPIRATORY CARE DEVICES GLOBAL MARKET SHARE 96
3.8.2 VENTILATOR GLOBAL MARKET SHARE ANALYSIS 100
3.8.3 PAP GLOBAL MARKET SHARE ANALYSIS 103
3.8.4 CPAP GLOBAL MARKET SHARE ANALYSIS 105
3.8.5 APAP GLOBAL MARKET SHARE ANALYSIS 106
3.8.6 BPAP GLOBAL MARKET SHARE ANALYSIS 108
3.9 REIMBURSEMENT SCENARIO 109
3.10 TECHNOLOGICAL ADVANCEMENTS 112
3.10.1 INTEGRATED DEVICES 113
3.10.2 NON – INVASIVE NANOSENSOR BASED WEARBLE RESPIRATORY MONITORING 113
3.10.3 AI BASED RESPIRATORY MONITORING 114
3.10.4 HIGH VELOCITY THERAPY 115
3.10.5 DIGITAL TECHNOLOGIES IN RESPIRATORY DEVICES 115
3.10.6 ADVANCED NEONATAL RESPIRATORY SOLUTIONS 116
3.10.6.1 Neonatal lung monitoring 116
3.10.6.2 Neovent 117
3.10.7 SELF - CARE RESPIRATORY MONITOR 117
3.11 FUNDING SCENARIO 117
3.12 CLINICAL TRIALS 124
4 RESPIRATORY CARE DEVICES GLOBAL MARKET, BASED ON PRODUCTS 127
4.1 INTRODUCTION 127
4.2 THERAPEUTIC RESPIRATORY CARE DEVICES 131
4.2.1 HUMIDIFIERS 134
4.2.1.1 Active humidifiers 138
4.2.1.2 Passive humidifiers 141
4.2.2 NEBULIZERS 143
4.2.2.1 Jet nebulizers 148
4.2.2.2 Ultrasonic nebulizers 150
4.2.2.3 Mesh nebulizers 153
4.2.2.4 Smart nebulizers 156
4.2.3 OXYGEN CONCENTRATORS 157
4.2.3.1 Stationary oxygen concentrators 162
4.2.3.2 Portable oxygen concentrators 164
4.2.4 POSITIVE AIRWAY PRESSURE DEVICES (PAP) 166
4.2.4.1 Continuous pap devices (CPAP) 171
4.2.4.2 Automatic pap (APAP) devices 173
4.2.4.3 Bbi-level pap (BPAP) devices 175
4.2.5 RESUSCITATORS 177
4.2.5.1 Manual resuscitators 181
4.2.5.2 Gas powered resuscitators 183
4.2.6 VENTILATORS 185
4.2.7 VENTILATORs MARKET BASED ON TYPE 190
4.2.7.1 ICU ventilators 192
4.2.7.2 Emergency and transport ventilators 195
4.2.7.3 Others 197
4.2.8 VENTILATORs MARKET BASED ON END-USERS 199
4.2.9 INHALERS 208
4.2.9.1 Dry powder inhalers 212
4.2.9.2 Metered dose inhalers 215
4.2.9.3 Soft mist inhalers 218
4.2.10 NEUROMODULATION DEVICES 221
4.2.11 AIRWAY CLEARANCE DEVICES AND OTHERS 224
4.3 MONITORING RESPIRATORY CARE DEVICES 235
4.3.1 PULSE OXIMETERS 239
4.3.1.1 Finger pulse oximeters 243
4.3.1.2 Handheld pulse oximeters 244
4.3.1.3 Tabletop pulse oximeters 246
4.3.1.4 Others 247
4.3.2 CAPNOGRAPHS 249
4.3.3 GAS ANALYZERS AND OTHERS 251
4.4 DIAGNOSTIC RESPIRATORY CARE DEVICES 253
4.4.1 SPIROMETERS 257
4.4.1.1 Volumetric spirometers 261
4.4.1.2 Flow measuring spirometers 263
4.4.2 PEAK FLOW METERS 265
4.4.3 POLYSOMNOGRAPH DEVICES (PSG) 267
4.4.3.1 Clinical polysomnography devices 270
4.4.3.2 Ambulatory polysomnography devices 271
4.4.4 RESPIRATORY POLYGRAPH 273
4.4.5 OTHER DIAGNOSTIC DEVICES 274
4.5 CONSUMABLES 276
4.5.1 MASKS 280
4.5.1.1 Full face masks 283
4.5.1.2 Nasal masks 284
4.5.1.3 Nasal pillow masks 286
4.5.1.4 Other masks 287
4.5.2 AIRWAY MANAGNEMNT APPLIENCES 289
4.5.3 NASAL CANNULAS 293
4.5.4 FILTERS 295
4.5.5 OTHER CONSUMABLES 296
5 RESPIRATORY CARE DEVICES GLOBAL MARKET, BASED ON
APPLICATION 299
5.1 INTRODUCTION 299
5.2 OBSTRUCTIVE RESPIRATORY CONDITION 301
5.2.1 CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) 306
5.2.1.1 Chronic bronchitis 311
5.2.1.2 Emphysema 313
5.2.2 ASTHMA 314
5.2.3 CYSTIC FIBROSIS 316
5.2.4 OBSTRUCTIVE SLEEP APNEA (OSA) 318
5.3 RESTRICTIVE RESPIRATORY CONDITION 321
5.3.1 ARDS 325
5.3.2 RESTRECTIVE LUNG DISEASES AND OTHERS 326
5.4 VASCULAR DISEASES 328
5.4.1 PULMONARY FIBROSIS 332
5.4.2 PULMONARY EDEMA 334
5.4.3 PULMONARY HYPERTENSION (PH) 335
5.5 INFECTIOUS RESPIRATORY CONDITION 337
5.5.1 PNEUMONIA 341
5.5.2 TUBERCULOSIS 342
5.5.3 COVID - 19 344
5.6 OTHERS 346
6 RESPIRATORY CARE DEVICES GLOBAL MARKETY, BASED ON END-USERS 348
6.1 INTRODUCTION 348
6.2 HOSPITALS 351
6.2.1 EMERGENCY CARE 355
6.2.2 CRITICAL CARE/INTENSIVE CARE UNIT (ICU) 357
6.2.3 ACUTE CARE 358
6.2.4 SLEEP CENTER UNIT 359
6.2.5 OTHER HOSPITAL CARE SETTINGS (OPD) 360
6.3 HOME HEALTH CARE 361
6.4 AMBULATORY SURGICAL CENTERS 363
7 REGIONAL MARKET ANALYSIS 365
7.1 INTRODUCTION 365
7.2 NORTH AMERICA 370
7.2.1 UNITED STATES (U.S.) 418
7.2.2 REST OF NORTH AMERICA 422
7.3 EUROPE 425
7.3.1 GERMANY 474
7.3.2 ITALY 477
7.3.3 FRANCE 479
7.3.4 REST OF EUROPE 482
7.4 ASIA-PACIFIC 485
7.4.1 JAPAN 534
7.4.2 CHINA 536
7.4.3 INDIA 538
7.4.4 REST OF APAC 541
7.5 REST OF THE WORLD 544
7.5.1 BRAZIL 593
7.5.2 REST OF LATIN AMERICA 595
7.5.3 MIDDLE EAST AND OTHER COUNTRIES 597
8 COMPANY DEVELOPMENTS 600
8.1 INTRODUCTION 600
8.2 NEW PRODUCT LAUNCHES 601
8.3 APPROVALS 604
8.4 AGREEMENT 605
8.5 EXPANSION 605
9 MAJOR COMPANIES 607
9.1 AIR LIQUIDE S.A 607
9.1.1 OVERVIEW 607
9.1.2 FINANCIALS 608
9.1.3 PRODUCT PORTFOLIO 609
9.1.4 KEY DEVELOPMENTS 610
9.1.5 BUSINESS STRATEGY 610
9.1.6 SWOT ANALYSIS 611
9.2 DRAGERWERK AG & CO. KGAA 612
9.2.1 OVERVIEW 612
9.2.2 FINANCIALS 613
9.2.3 PRODUCT PORTFOLIO 614
9.2.4 KEY DEVELOPMENTS 615
9.2.5 BUSINESS STRATEGY 616
9.2.6 SWOT ANALYSIS 616
9.3 FISHER AND PAYKEL HEALTHCARE CORPORATION LIMITED 617
9.3.1 OVERVIEW 617
9.3.2 FINANCIALS 618
9.3.3 PRODUCT PORTFOLIO 621
9.3.4 KEY DEVELOPMENTS 623
9.3.5 BUSINESS STRATEGY 624
9.3.6 SWOT ANALYSIS 625
9.4 INSPIRE MEDICAL SYSTEM, INC. 626
9.4.1 OVERVIEW 626
9.4.2 FINANCIALS 627
9.4.3 PRODUCT PORTFOLIO 628
9.4.4 KEY DEVELOPMENTS 628
9.4.5 BUSINESS STRATEGY 629
9.4.6 SWOT ANALYSIS 630
9.5 GETINGE GROUPS 631
9.5.1 OVERVIEW 631
9.5.2 FINANCIALS 632
9.5.3 PRODUCT PORTFOLIO 634
9.5.4 KEY DEVELOPMENTS 634
9.5.5 BUSINESS STRATEGY 634
9.5.6 SWOT ANALYSIS 635
9.6 MASIMO CORPORATION 636
9.6.1 OVERVIEW 636
9.6.2 FINANCIALS 637
9.6.3 PRODUCT PORTFOLIO 638
9.6.4 KEY DEVELOPMENTS 639
9.6.5 BUSINESS STRATEGY 639
9.6.6 SWOT ANALYSIS 640
9.7 MEDTRONIC, PLC 641
9.7.1 OVERVIEW 641
9.7.2 FINANCIALS 642
9.7.3 PRODUCT PORTFOLIO 645
9.7.4 KEY DEVELOPMENTS 648
9.7.5 BUSINESS STRATEGY 649
9.7.6 SWOT ANALYSIS 650
9.8 PHILIPS N.V. 651
9.8.1 OVERVIEW 651
9.8.2 FINANCIALS 652
9.8.3 PRODUCT PORTFOLIO 653
9.8.4 KEY DEVELOPMENTS 658
9.8.5 BUSINESS STRATEGY 658
9.8.6 SWOT ANALYSIS 659
9.9 RESMED INC. 660
9.9.1 OVERVIEW 660
9.9.2 FINANCIALS 661
9.9.3 PRODUCT PORTFOLIO 662
9.9.4 KEY DEVELOPMENTS 664
9.9.5 BUSINESS STRATEGY 664
9.9.6 SWOT ANALYSIS 666
9.10 VYAIRE MEDICAL, INC. 667
9.10.1 OVERVIEW 667
9.10.2 FINANCIALS 667
9.10.3 PRODUCT PORTFOLIO 667
9.10.4 KEY DEVELOPMENTS 669
9.10.5 BUSINESS STRATEGY 670
9.10.6 SWOT ANALYSIS 671
Related Report
